<DOC>
	<DOCNO>NCT02143895</DOCNO>
	<brief_summary>Evaluation effect etifoxine versus benzodiazepine ( lorazepam ) vigilance cognitive function elderly .</brief_summary>
	<brief_title>Evaluation Effects Etifoxine 100 mg Lorazepam 2 mg Vigilance Cognitive Functions Elderly</brief_title>
	<detailed_description>Evaluation effect etifoxine 100 mg lorazepam 2 mg , single dose intake , vigilance cognitive function elderly .</detailed_description>
	<mesh_term>Lorazepam</mesh_term>
	<mesh_term>Etifoxine</mesh_term>
	<criteria>Man woman age 65 75 year Righthanded subject ( Edinburgh Handedness inventory ) Subject sign consent form Subject agree list French National Healthy Volunteers database Subject affiliate beneficiary French social insurance Subject present neurological psychiatric disease notably cognitive , progress Anxious subject ( Hamilton score &gt; 7 and/or Spielberger score &gt; 51 man &gt; 61 woman ) Lefthanded subject ( Edinburgh Handedness inventory ) Subject present correct visual disease motor function disease could interfere test realization Smoker Subject take one psychotrops apparented product Subject take , previous month , one drug could interfere study drug metabolism Subject drinking much coffee tea ( &gt; 4 cup per day ) alcohol ( &gt; Â½ liter wine equivalent per day ) Subject present contraindication one drug use study Subject past history intolerance drug use study Subject capable use CANTAB cognitive evaluation system Subject may able participate whole study Subject tutelage guardianship Subject able wellunderstand French understand cognitive test Subject capable swallow capsule Subject participate another study exclusion period ( 3 month previous trial ) .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>